Alpha Insights

Cannabis Tipping Point: Rescheduling Redefines the Investment Thesis

Written by AdvisorShares | Apr 23, 2026 9:08:36 PM

 
For years, the U.S. cannabis industry has operated under a paradoxical cloud: robust consumer demand and state-level legality clashing with restrictive federal classification. That landscape is shifting. With cannabis rescheduling moving forward, financial professionals must evaluate how this regulatory pivot transforms the sector from a speculative play into a fundamental growth story.

 

The Catalyst: Federal Rescheduling and the 280E Factor

The transition of cannabis to a lower-tier controlled substance is more than a symbolic victory; it is a fundamental economic driver for U.S. operators.

  • Removal of IRS Section 280E: Currently, cannabis companies face severe tax penalties under Section 280E, which prevents them from deducting standard business expenses. Its removal could significantly boost net income and free cash flow for multi-state operators. 

  • Healthier Capital Structures: Rescheduling paves the way for lower financing costs and expanded lending channels, potentially improving capital access for leading operators. 

  • Institutional Infusion: A shift in federal status lowers the barrier for institutional participation, which we expect will improve market liquidity and support higher valuations.  

Market Sentiment: A Growing Supermajority

Public opinion and state-level access have already reached a critical mass, creating a massive, untapped market.

  • Widespread Acceptance: 87% of U.S. adults believe cannabis should be legal in some form (54% for both medical and recreational use, 33% for medical only).1

  • Demographic Reach: 75% of the U.S. population currently lives in a state where cannabis is legal in some capacity.2 

  • Economic Tailwinds: The growth of legal access is projected to drive added tax revenue, create new employment opportunities, and expand medical research. 

Global Growth and Valuation Gap

While global cannabis revenue is forecasted to climb steadily through 2029, current valuations for many U.S. companies remain well below their historical peaks. This creates a potentially attractive entry point as fundamentals improve and market access expands.

Strategizing Exposure: Active Management in a Volatile Space

Given the complexities of state-versus-federal regulations and the volatility of the cannabis industry, active management is a critical tool for navigating this sector.

 AdvisorShares provides three distinct pathways for professional portfolios: 

  1. Pure U.S. Exposure | AdvisorShares Pure US Cannabis ETF (MSOS): The largest U.S.-focused cannabis ETF, concentrated in top MSOs with scale and market share. 

  2. Global Diversification | AdvisorShares Pure Cannabis ETF (YOLO): Provides exposure to both U.S. and international cannabis markets. 

  3. Magnified Exposure | AdvisorShares MSOS Daily Leveraged ETF (MSOX): A daily leveraged ETF for sophisticated investors seeking to amplify exposure or overweight the theme with less cash. 

Are Your Clients Positioned for the Rescheduling Shift?

As the federal landscape evolves, the gap between cannabis "potential" and "performance" is narrowing. Schedule time with us to learn how our actively managed strategies can fit into a diversified portfolio and what makes our approach to cannabis investing different.

 

 

NOTE ON RISK: Cannabis-related companies face unique risks, including regulatory shifts, agricultural dependencies, and intellectual property challenges. Leveraged products, like MSOX, carry high volatility risks and are intended for active daily monitoring. 
 
1 Source: Pew Research Center, survey conducted Jan. 27–Feb. 2, 2025.
2 Source: DISA Global Solutions, Inc., as of Sep. 30,2025; U.S. Census Bureau 2020 data.
———————————————————————————————————— 
 
— For Institutional Investor Use Only. Not for Public Distribution —
Before investing you should carefully consider the Fund’s investment objectives, risks, charges and expenses. This and other information is in the prospectus and summary prospectus, a copy of which may be obtained by visiting the Fund’s website at www.AdvisorShares.com. Please read the prospectus carefully before you invest. Foreside Fund Services, LLC, distributor.
 
An investment in the Funds is subject to risk, including the possible loss of principal amount invested. The risks associated with each Fund include the risks associated with the underlying ETFs, which can result in higher volatility, and are detailed in each Fund’s prospectus and on each Fund’s webpage.
AIL-924326-2026-04-22
View full post